Pathogenic autoantibodies in the lambert-eaton myasthenic syndrome.

Pathogenic autoantibodies in the lambert-eaton myasthenic syndrome.

Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmune disorder of neuromuscular transmission in which antibodies are directed against voltage-gated calcium channels (VGCCs). We studied the action of LEMS immunoglobulin G (IgG) on cloned human VGCCs stably transfected into human embryonic kidney...

Descripció completa

Dades bibliogràfiques
Autors principals:	Lang, B, Pinto, A, Giovannini, F, Newsom-Davis, J, Vincent, A
Format:	Journal article
Idioma:	English
Publicat:	2003

Ítems similars

Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
per: Bain, P, et al.
Publicat: (1996)

Autoantibodies in the Lambert-Eaton myasthenic syndrome (LEMS) and amyotrophic lateral sclerosis (ALS)
per: Lang, B
Publicat: (2007)

Autoantibodies in the Lambert-Eaton Myasthenic Syndrome (LEMS) and Amyotrophic Lateral Sclerosis (ALS)
per: Lang, B, et al.
Publicat: (2013)

Incidence of serum anti-P/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
per: Motomura, M, et al.
Publicat: (1997)

Long term outcome in Lambert-Eaton myasthenic syndrome without lung cancer.
per: Maddison, P, et al.
Publicat: (2001)

Type 2 fiber predominance in Lambert-Eaton myasthenic syndrome.
per: Squier, M, et al.
Publicat: (1991)

Prospective study into the incidence of Lambert Eaton myasthenic syndrome in small cell lung cancer.
per: Payne, M, et al.
Publicat: (2010)

The action of Lambert-Eaton myasthenic syndrome immunoglobulin G on cloned human voltage-gated calcium channels.
per: Pinto, A, et al.
Publicat: (2002)

Non-paraneoplastic Lambert-Eaton myasthenic syndrome with severe gastrointestinal dysfunction. Case report
per: Cruz, M, et al.
Publicat: (2005)

Myasthenia gravis and Lambert-Eaton myasthenic syndrome
per: Palace, J, et al.
Publicat: (2004)

Lambert-Eaton myasthenic syndrome and survival in patients with small cell lung carcinoma
per: Lang, B, et al.
Publicat: (2008)

Lambert Eaton myasthenic syndrome and pregnancies with the development of transient myasthenic syndrome in newborn
per: N. I. Shcherbakova, et al.
Publicat: (2015-02-01)

Cerebellar ataxia in non-paraneoplastic Lambert-Eaton myasthenic syndrome.
per: Lorenzoni, P, et al.
Publicat: (2008)

Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies.
per: Titulaer, M, et al.
Publicat: (2011)

Nationwide survey of Lambert-Eaton myasthenic syndrome in Japan
per: Yutaka Furukawa, et al.
Publicat: (2022-09-01)

062 Pembrolizumab induced lambert-eaton myasthenic syndrome
per: Rob Zielinski, et al.
Publicat: (2021-08-01)

The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
per: Maddison, P, et al.
Publicat: (2011)

HLA-B8 in patients with the Lambert-Eaton myasthenic syndrome reduces likelihood of associated small cell lung carcinoma.
per: Wirtz, P, et al.
Publicat: (2003)

Prediction model for small-cell lung cancer in the Lambert-Eaton myasthenic syndrome
per: Titulaer, M, et al.
Publicat: (2010)

Pseudomyopathic Changes in Needle Electromyography in Lambert-Eaton Myasthenic Syndrome
per: Teppei Komatsu, et al.
Publicat: (2013-01-01)

Electrophysiological and muscle pathological characteristics of Lambert - Eaton myasthenic syndrome
per: SUN Qing, et al.
Publicat: (2024-10-01)

Autoantibodies in different forms of myasthenia gravis and in the Lambert-Eaton syndrome.
per: Vincent, A
Publicat: (2008)

Burden of disease in Lambert-Eaton myasthenic syndrome: taking the patient’s perspective
per: Lehnerer, S, et al.
Publicat: (2024)

Electron microscopic study of skeletal muscle in the Lambert–Eaton myasthenic syndrome
per: L. L. Babakova, et al.
Publicat: (2015-02-01)

Atypical Presentation of Seronegative Paraneoplastic Lambert–Eaton Myasthenic Syndrome with Cerebellar Ataxia
per: Shalesh Rohatgi, et al.
Publicat: (2024-06-01)

Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome: New Developments in Diagnosis and Treatment
per: Pascuzzi RM, et al.
Publicat: (2022-12-01)

Non-paraneoplastic Lambert-Eaton myasthenic syndrome: a brief review of 10 cases
per: Paulo J. Lorenzoni, et al.
Publicat: (2010-12-01)

HLA and smoking in prediction and prognosis of small cell lung cancer in autoimmune Lambert-Eaton myasthenic syndrome.
per: Wirtz, P, et al.
Publicat: (2005)

Neuromuscular Active Zone Structure and Function in Healthy and Lambert-Eaton Myasthenic Syndrome States
per: Scott P. Ginebaugh, et al.
Publicat: (2022-05-01)

Truncal Ataxia: An Overlooked Symptom in Patients with Lambert–Eaton Myasthenic Syndrome in the Early Stage
per: Betül Özenç, et al.
Publicat: (2024-06-01)

Lambert-Eaton myasthenic syndrome against the background of thyroid cancer: a clinical case
per: Elena V. Khozhenko, et al.
Publicat: (2024-04-01)

P/Q-type calcium channel antibodies, Lambert-Eaton myasthenic syndrome and survival in small cell lung cancer.
per: Wirtz, P, et al.
Publicat: (2005)

Lambert-Eaton Syndrome in Children
per: J Gordon Millichap, et al.
Publicat: (2014-02-01)

Spontaneously resolving paraneoplastic ocular flutter-opsoclonus-myoclonus syndrome in association with treatment-sensitive Lambert-Eaton myasthenic syndrome
per: Simister, R, et al.
Publicat: (2006)

Lambert-Eaton Myasthenic Syndrome: A Review of Rare Neuromuscular Disease Related to Paraneoplastic and Autoimmune
per: Ichlasul Mahdi Fardhani, et al.
Publicat: (2025-01-01)

Efficacy of durvalumab plus chemotherapy in small-cell lung cancer with Lambert-Eaton myasthenic syndrome
per: Naoya Ishibashi, et al.
Publicat: (2024-01-01)

Lambert-Eaton Myasthenic Syndrome Caused by Nivolumab in a Patient with Squamous Cell Lung Cancer
per: Yuki Nakatani, et al.
Publicat: (2018-12-01)

A prospective study of the incidence of sub-clinical Lambert-Eaton myasthenic syndrome (LEMS) in patients with small cell lung cancer (SCLC)
per: Bradbury, P, et al.
Publicat: (2004)

A prospective study of the incidence of sub-clinical Lambert-Eaton Myasthenic Syndrome (LEMS) in patients with small cell lung cancer (SCLC).
per: Bradbury, P, et al.
Publicat: (2004)

Adenocarcinoma pulmonar, dermatomiosite e síndrome miastênica de Lambert-Eaton: uma rara associação Lung adenocarcinoma, dermatomyositis, and Lambert-Eaton myasthenic syndrome: a rare combination
per: Fernanda Manente Milanez, et al.
Publicat: (2008-05-01)